Study: Actual Number of COVID-19 Cases Vastly Underestimated
According to the findings, on average, only 6% of actual SARS-CoV-2 infections have been detected worldwide, meaning that the vast majority of infections have gone undetected.
First Successful Medical Drone Delivery Supplies ‘Full Circle’ Diabetes Care
The successful maiden flight of an autonomous drone delivering insulin shows the potential for drone use in the delivery of lifesaving medications and supplies during disasters.
Communicating with Patients in the Time of COVID-19
Pharmacies, just as expected, have showed up in meaningful ways to support their communities.
Incyte, Novartis Plan Phase 3 Trial for Ruxolitinib in COVID-19
The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.
FDA to Accelerate Development of Blood-Related Therapies for COVID-19
The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.
FDA OKs Ixekizumab for Pediatric Patients with Plaque Psoriasis
Officials with the FDA have granted approval to ixekizumab (Taltz, Eli Lilly) injection, 80 mg/mL for the treatment of pediatric patients with moderate-to-severe plaque psoriasis.
FDA Approves Luspatercept-aamt for Anemia in Lower-Risk Myelodysplastic Syndromes
Officials with the FDA have approved luspatercept-aamt (Reblozyl, Bristol Myers Squibb and Acceleron Pharma) for the treatment of anemia in adults with lower-risk myelodysplastic syndromes.
Many Hospital Pharmacists Report Moderate-to-Major Disruptions in Mask Supply
Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.
Coronavirus News Roundup: FDA Emergency Use Authorizations, Vaccine Candidate, and Virtual Blood Drives
Here's a roundup of the latest coronavirus-related news.
FDA OKs Treatment for Hemophilia A or B with Inhibitors
Coagulation factor VIIa (recombinant)-jncw (Sevenfact, LBF) contains an active ingredient from a genetically engineered animal.
Studies Examine Association Between Opioid Prescriptions and Obesity
Obesity may contribute to incident long-term prescription opioid use due to underlying pain conditions.
Please Donate Blood!
During times like these, we must come together and help those in need.
Rimegepant Demonstrates Efficacy in Prevention of Migraine
Rimegepant (Nurtec ODT, Biohaven Pharmaceuticals) reduced monthly migraine days in patients with episode and chronic migraine in a clinical trial.
Clinical Trial Tests Efficacy of Short-Acting GLP-1 Receptor Agonist in Type 1 Diabetes
A clinical trial funded by AstraZeneca evaluated the use of short-acting GLP-1 receptor agonists as an add-on treatment to insulin therapy in type 1 diabetes.
FDA Requests Removal of All Ranitidine from Market
Officials with the FDA have requested that manufacturers of all ranitidine (Zantac) drugs, both prescription and over-the-counter, remove their products from the market.
Bempedoic Acid Tablets Now Available in Pharmacies
Bempedoic acid (Nexletol, Esperion), an oral, once-daily, non-statin low-density lipoprotein-cholesterol lowering medicine, is now available in US pharmacies.
Community Pharmacies Project Successful in Increasing Adult Vaccinations
The purpose of the project was to increase the number of influenza, pertussis, pneumococcal, and herpes zoster vaccines provided to adults.
RxSafe LLC Launches ViralGuardRx COVID-19 Protection
As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances.
What Is Disseminated Zoster?
Less common but more communicable than localized zoster
Ticagrelor Monotherapy Shows Cardiovascular Benefit in Patients with Diabetes
Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.
How Are Pharmacies Protecting Staff from COVID-19?
Concerns about adequate protection from COVID-19 have led to several efforts from chain pharmacies to keep pharmacy staff and employees safe.
FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer
Officials with the FDA have approved durvalumab (Imfinzi) for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), in combination with standard-of-care (SoC) chemotherapies, in adult patients.
Alirocumab Evaluated for Treatment of Homozygous Familial Hypercholesterolemia
Alirocumab significantly reduced low-density lipoprotein cholesterol in adults with homozygous familial hypercholesterolemia, according to phase 3 data.
Johnson & Johnson Announces COVID-19 Vaccine Candidate
Johnson & Johnson expects to initiate human clinical studies for its lead COVID-19 vaccine candidate by September 2020.
FDA Permits Emergency Use of Experimental Treatments for COVID-19
Chloroquine and hydroxychloroquine have been authorized to treat hospitalized patients with COVID-19.
FDA Issues Emergency Use Authorization for ‘Game Changer’ COVID-19 Test
Abbott’s ID NOW COVID-19 test is able to deliver results in as little as 5 minutes.
10 Facts About Varicella Zoster Virus
Things to know about the root cause of chickenpox and shingles
Coronavirus News Roundup: Inhaler Shortages, Updates on Potential Treatments
Here’s a roundup of the latest coronavirus-related news from this week.
FDA Approves Ozanimod for Relapsing Multiple Sclerosis
Officials with the FDA have granted approval to ozanimod (Zeposia, Bristol Myers Squibb) for the treatment of relapsing multiple sclerosis.
Gilead to Rescind Orphan Drug Status for Remdesivir, a Potential COVID-19 Treatment
Gilead has now asked the FDA to rescind its orphan drug status for the potential COVID-19 therapy.